Objective: The objective of this study is to investigate the influence of the day-to-day variability of the measures of heart rate variability (HRV) on the sample size calculation for the study of cardiac autonomic neuropathy. Material and methods: We analyzed HRV in the frequency domain [very low (VLF), low (LF), and high frequency (HF) bands] and in the time domain [the root mean squared of successive RR intervals differences (RMSSD); the mean RR intervals (RRNN); the standard deviation of RR intervals (SDNN) and the coefficient of variation (CV)] during a 5-min electrocardiogram record. We also analyzed the heart rate response to deep breathing [expiration:inspiration ratio], to the Valsalva maneuver and to standing [maximum:minimum ratio] and the blood pressure response to standing. The day-to-day variability was assessed by calculating the within-subject standard deviations (WSSD), limits of agreement, typical errors and the ratio of the WSSD to the mean values obtained on days 1 and 2 (WSSD/GM). Results: Sixty-seven healthy subjects (45 females), aged 27 (19-39) years, were recruited. The RMSSD, CV, VLF, LF, HF and blood pressure response to standing showed marked variability (WSDD/GM (%) = 237. 7, 455.1, 69.9, 126.5, 81.3 and 380.5, respectively), while the RRNN, SDNN, Valsalva, expiration:inspiration and maximum:minimum ratio showed less variability (WSSD/GM (%) = 6. 4, 24.5, 18.6, 11.0 and 14.1, respectively). The minimum differences expected to be statistically significant for the autonomic measurements were calculated. Conclusion: Some tests that assess HRV showed adequate reproducibility. This study allows the determination of a sample size calculation for longitudinal or drug-testing studies.
Introduction
Cardiovascular autonomic neuropathy (CAN) is one of the most common chronic complications of diabetes mellitus and, despite its significant negative impact on survival and quality of life, is among the least recognized and understood complication of the disease (Rolim et al., 2008; Vinik et al., 2011) .
Clinical symptoms of CAN generally do not occur until long after the onset of the disease, which makes the use of noninvasive electrocardiographic tests critical for assessing the overall autonomic activity (Vinik et al., 2003) .
The prevalence of CAN ranges from 2.6% to 90% among persons with diabetes, depending on the diabetes duration and the methodology and diagnostic criteria used in various studies (Schmid, 2007) .
However, because a patient's history and physical examination are insufficient for the early detection of CAN, tests for the evaluation of heart rate variability (HRV), including the expiration to inspiration ratio and the heart rate response to the Valsalva maneuver and standing, in addition to specialized tests based on components of the spectral analysis of HRV, such as the beat-to-beat HRV and different bands of spectral analysis [very low (VLF) , low (LF) and high frequency (HF) and low to high frequency ratio (LF/HF)], can be used to assess the cardiovascular autonomic system and to diagnose CAN (Boulton et al., 2005) .
The diagnosis of CAN is based on maneuvers capable of investigating the autonomic nervous system (ANS) activity of the heart. An abnormality at any point in the reflex arc of the cardiovascular ANS can alter end-organ function and can be influenced by many factors, such as eating, obesity, drinking coffee, smoking, ethanol, exercise, stress, fever, hypo-or hyperglycemia and medications, such as aspirin, antihistamines, nasal sprays, β-blockers and anti-arrhythmic agents (Dyck and Thomas, 1999; Kowalewski and Urban, 2004) .
The performance of cardiovascular reflex tests should be standardized regarding the period of fasting, the number and type of tests required for diagnosis, the duration of the test (spectral analysis of short or long term), the reference values stratified for sex and age, the differences in the statistical analysis tests (logarithmic transformation of variables and statistical methods, such as intraclass correlation coefficient, coefficient of variation, standard deviation, reliability coefficient and Bland-Altmann method) and the intervals between subsequent tests (O'Brien et al., 1986; Ziegler et al., 1992; Gerritsen et al., 2003; Lobnig et al., 2003; Kowalewski and Urban, 2004) . Therefore, a proper assessment of tests for the cardiovascular autonomic function requires a standardization of the autonomic tests to avoid confounding factors that could influence these measurements (Kowalewski and Urban, 2004) .
Currently, seven parameters are used for the early detection of CAN (Halsbeck et al., 2006) as follows: the three spectral analysis frequency bands (VLF, LF and HF) and four tests proposed by Ewing (heart rate response to the Valsalva maneuver, to deep breathing and to standing and the blood pressure response to standing) (Ewing and Clarke, 1982) . According to the consensus recommendations (American Diabetes Association and American Academy of Neurology, 1988; American Diabetes Association, 1992; Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology, 1996; Vinik et al., 2003) , a diagnosis of incipient and definitive CAN is made when at least two and three of the seven tests are abnormal with a specificity of 98% and 100%, respectively.
The present study was designed to investigate the day-to-day variability of measurements of HRV with physiological stimuli in young, healthy volunteers. In view of our results, we propose the use of a statistical methodology to calculate sample size in longitudinal clinical studies and studies testing drugs that takes into consideration the reproducibility of the autonomic tests.
Material and methods
This study was performed on 67 healthy volunteers without any underlying diseases (hospital employees and medical students). None of the subjects were taking any medications, but all women used oral contraceptives, and they were all judged to be healthy on the basis of a physical examination and routine laboratory screening, which revealed normal lipid and glycemic profiles. Each individual was investigated on two different days in the morning (all of the subjects were tested at 1-day interval).
The subjects were instructed to refrain from drinking alcohol-or caffeine-containing beverages and to engage in smoking cessation for a minimum of 8 h prior to testing and to refrain from strenuous exercise for at least 24 h preceding the examination. The exclusion criteria were fever in the last two days, emotional distress on the day before the autonomic tests and arrhythmias.
Autonomic tests were performed in the morning. Subjects were instructed to assume the supine position in a metabolic unit with a controlled temperature (23°C) after an overnight fast or at least 2 h after a light meal (containing a total of 300 Kcal) standardized by a dietitian.
After 10 min of rest in the supine position with the head elevated 45°, an electrocardiogram (EKG) was recorded during 5 min of spontaneous breathing using a computer software (VNS-Rhythm/ Software Poly-Spectrum analysis). The EKG was analyzed by a mathematical algorithm (fast Fourier transform) and expressed in a diagram of oscillation amplitude (heart rate variations per second) versus frequency (hertz), that providing a simultaneous study of the heart rate. The 5 min EKG recording was controlled by the operator in order to maintain control breathing at 15 breaths/min and the subjects were instructed to avoid irregular or deep breathing.
From 150 RR intervals that were free of artifacts, the computer calculated the mean RR intervals (RRNN), the standard deviation of RR intervals (SDNN), the coefficient of variation (CV) (the standard deviation of the distribution of RR intervals divided by the mean) and the root mean squared of successive RR interval differences (RMSSD).
The total spectral amplitude of HRV was composed of the three frequency bands of spectral analysis, which reflect the relative impact of the sympathetic and parasympathetic modulation on the HRV (Vinik and Ziegler, 2007) . The VLF component (0.01 to 0.04 Hz) is related to fluctuations in the vasomotor tonus that is linked to thermoregulation and sweating (sympathetic control). The LF component (0.04 to 0.15 Hz) is associated with the baroreflex (sympathetic control with vagal modulation), and the HF component (0.15 to 0.5 Hz) is related to sinus arrhythmia (parasympathetic control) (Vinik and Ziegler, 2007) .
The cardiovascular reflex tests (deep breathing test, Valsalva maneuver, orthostatic test and hypotension orthostatic test) were also performed. After each test, a resting period of 1 min was scheduled to prevent influences by the previous tests.
The deep breathing test was performed 3 times. The subjects were instructed to start the test with a deep and slow inspiration to the maximum total lung capacity for 5 s, which was followed by a forced expiration down to the residual volume for 5 s. The time to alternate the respiratory cycle was signaled directly to the patient by the operator. The expiration:inspiration ratio (E:I ratio) was determined by the ratio between the longest and shortest RR intervals obtained during the expiration and inspiration cycles, respectively, and the highest E:I ratio was considered (Spallone et al., 2011) .
The Valsalva maneuver was performed 2 times and the subjects were invited to blow with an open glottis into a mouthpiece connected to a manometer and to maintain a constant expiratory effort equivalent to an intraoral pressure of 40 mm Hg for 15 s. This test induces a physiological tachycardia, which persists for a maximum of approximately 14 s. After this period, the expiratory straining was suddenly released, and the subject should breathe regularly and remain silent and motionless until the end of the test, when the physiological bradycardia was observed. The Valsalva ratio was determined by the ratio between the longest and shortest RR intervals (Ziegler et al., 1992; Rolim et al., 2008) .
To perform the orthostatic test, the subjects were invited to stand up quickly but remain relaxed with their arms at rest alongside the body and without speaking or moving until the end of the test (180 s after standing up). The 30:15 or maximum:minimum (max:min) ratio was determined by the ratio between the longest (maximum bradycardia at approximately the 30th beat) and shortest (maximum tachycardia at approximately the 15th beat) RR interval. During the orthostatic test, the blood pressure was measured at baseline and after 3 min of standing. A drop in the systolic blood pressure (sBP) higher than or equal to 20 mm Hg was considered abnormal, and a drop in sBP between 10 and 19 mm Hg was considered borderline (Rolim et al., 2008; Spallone et al., 2011) .
The study was approved by the local ethics committee, and the participants gave written informed consent.
Data and statistical analysis
Analysis of the day-to-day variability was carried out using the limits of agreement due to its straightforward interpretation and using the within-subject standard deviation (WSSD), which is easy to use in sample size calculations. Heteroscedasticity was checked and was not present in the data. The WSSD was calculated as the standard error of the mean of the variances obtained between days 1 and 2 for each subject and given by WSSD ¼
where n is the sample size and d is the number of measurements obtained for each subject. The WSSD was used in the calculations of the sample sizes. The significance of the mean error between day 1 and day 2 was calculated using the t-test for dependent samples (paired t-tests), which was adjusted to the multiple comparisons by the Sidák method.
Considering that there was a correlation between the error (interday variability) and the magnitude of the measurements, the data from spectral analysis (VLF, HF and LF) were logarithm transformed for the calculations of the limits of agreement, according to Altman and Bland, but the data from de minimum difference expected according to sample size are presented as ms 2 . The sample sizes were calculated for longitudinal studies, where the size of each group is given by n ¼ 2⋅ z
MDE indicating the minimum difference expected between measures. Using α = 0.05 (z α/2 = 1.96) and β = 0.20 (z 1 − β = 0.84), we can simplify the formula to n ¼ 16⋅ WSSD MDE 2 . We also calculated the minimum statistically significant differences according to the sample size of hypothetical study populations. An assessment of the reproducibility of the HRV measurements was realized between the two different days using the Bland-Altman analysis method. The Bland-Altman method calculates the mean difference between two measurement methods performed on repeat occasions and 95% limits of agreement as the difference of the means [1.96 standard deviation (SD)]. It is expected that the 95% limits include 95% of the differences between the two measurement methods Altman, 1986, 1999) . Random errors were assessed by both the limits of agreement and WSSD.
To compare the tests studied and to determine which is the most stable and adequate to use, we calculated a global mean (the mean of all individual values in days 1 and 2 for the same test) and divided the WSSD by this value, as a type of coefficient of variation. Tests with a smaller ratio between the WSSD and global mean would be the most stable and the best choice.
Results
The clinical and demographic data for the study population are shown in Table 1 .
The means and SD for each parameter are presented in Table 2 . There were no significant intra-subject differences between the baseline measurements on each of the study days. A significant p-value indicates a systematic error between days. These results indicate that there was no systematic error between the two days. Table 3 shows the limits of agreement in the day-to-day measurements of HRV using VNS-Rhythm. Using the criteria of the smaller ratio WSSD/global mean, the most reliable parameters were the Valsalva ratio, E:I ratio, max:min ratio and RRNN. A higher random error was found for the decrease in sBP, LF, RMSSD and CV.
The results of our study showed no difference between HF (3 ± 0.4 vs 3.1 ± 0.3; p = 0.112) and VLF (3.1 ± 0.3 vs 3.2 ± 0.3; p = 0.101), but lower levels of LF (3.1 ± 0.3 vs 3.3 ± 0.4; p = 0.026) in female when compared to male sex, respectively.
The sample size estimates using the minimum differences, which were expected to be statistically significant for the different autonomic measurement techniques in longitudinal studies using HRV tests, are presented in Table 4 . Table 4 presents the minimum difference to be considered statistically significant using various sample sizes, according to the calculated WSSD. The E:I ratio, Valsalva ratio and max:min ratio required the smallest sample size, and the decrease in sBP, VLF, LF or HF required a much larger sample size due to the large random error.
Discussion
Previous studies showed that the reproducibility of data from normal subjects demonstrates coefficients of variation of 6-8.9% for the E:I ratio, 8-15.4% for the Valsalva ratio and 5.3-9% for the max: min ratio (Spallone et al., 2011) . Our study showed that there is good reproducibility of the three tests proposed by Ewing, 11%, 18.6% and 14.1% for the E:I ratio, the Valsalva ratio and the max:min ratio, respectively, and for parameters obtained by spectral analyses, RRNN (6.4%) and SDNN (24.5%), which is in agreement with the literature data.
The results of this study showed that there were large limits of agreement in the day-to-day measurements of the E:I ratio, the max:min ratio, the Valsalva ratio and the CV, and there were important random errors in the measurements of the HF, VLF and LF components of spectral analysis and a decrease in the SBP after 3 min of standing in the healthy subjects. Moreover, we did not detect a systematic error in the measurements, as evidenced by the absence of statistically significant differences between the values of the HRV measurements between days 1 and 2.
Previous studies have shown reduced RR variation related to female gender (Vinik and Ziegler, 2007) . It is well known that the data from spectral analysis (VLF, HF and LF) are affected by sex, and the females The data are presented as counts (percentage), means ± SD or medians (minimum/maximum). BMI, body mass index; sBP, systolic blood pressure; dBP, diastolic blood pressure. have higher HF than males but lower LF than males (Ziegler et al., 1992) . Our study only demonstrates statistical difference in the LF band of spectral analysis which was lower in females when compared to males. This could be explained by the asymmetry of the study population (67% female sex). The minimum differences expected to be statistically significant according to the sample size for the different tests showed that the E:I ratio, the Valsalva ratio, the max:min ratio, the SDNN and the CV were much more adequate than the measurements obtained by the spectral analysis (VLF, LF, HF, RRNN and RMSSD).
There are few studies showing the reproducibility of the measurements of HRV by spectral analysis. We found that sample sizes of approximately 50 and 25 subjects respectively are necessary to detect changes of approximately 6.6% and 9.3% in RRNN; 13.9% and 20% in SDNN; 134.5% and 190% in RMSSD; 255% and 363% in CV; 6.7% and 6.7% in the E:I ratio; 10.3% and 15.4% in the Valsalva ratio; 6.7% and 13.3% in the max: min ratio; 71.6% and 101.2% in LH; 39.5% and 56% in VLF; 46% and 65% in HF; and a 222.2% and 333.3% decrease in sBP. Despite the high prevalence and the clinical and prognostic implications, CAN is still under-diagnosed. The methodology used for the diagnosis of CAN varies greatly between studies. Differences exist not only in the types of ANS function tests that are used (conventional tests or computerized HRV analysis) but also in the minimal diagnostic criteria for CAN (one or two tests or more), reference values, subject sample, duration of the HRV analysis (short-term assessment of 5 min or long-term assessment of 24 h), the subject's body position (sitting, lying or standing), breathing control (free breathing versus controlled breathing), selection of HRV indices (time domain or frequency domain variables) and the statistical procedures used (Ziegler, 1994) .
The majority of the studies that evaluated the reproducibility of the HRV parameters used to assess the autonomic nervous system were performed in healthy subjects (O'Brien et al., 1986; Ziegler et al., 1992; Gerritsen et al., 2003; Lobnig et al., 2003; Kowalewski and Urban, 2004) . These studies differ in some aspects including the length of fasting, time to retest, variables analyzed, methodology and the statistical method used to evaluate the reproducibility, which make the interpretation of the results and the comparison between studies difficult (O'Brien et al., 1986; Ziegler et al., 1992; Gerritsen et al., 2003; Lobnig et al., 2003; Kowalewski and Urban, 2004) .
It has been demonstrated that a combination of autonomic function tests based on standard, spectral and vector analyses is relatively more sensitive in detecting CAN than the traditional test battery proposed by Ewing and Clarke (Ziegler, 1994) . Furthermore, the detection of HRV by a spectral analysis has the advantage of being carried out at rest and does not require the active cooperation of the patient (Ziegler, 1994) .
Although it is low cost, non-invasive, operator independent, easy to perform and does not require the active cooperation of the patient, the HRV obtained by spectral analyses (LF, VLF and HF) demonstrates poor reproducibility in our study. Thus, the random error inherent in measurements of spectral analysis should be thoroughly evaluated when calculating the statistical power and sample sizes in longitudinal studies that evaluate the cardiovascular autonomic function as a diagnostic of CAN.
Based on reproducibility data some experts do not recommend the use of spectral analysis parameters for CAN diagnosis. The consensus statement of the 1992 San Antonio conference on diabetic neuropathy (American Diabetes Association and American Academy of Neurology, 1988) recommended using the battery of three cardiovascular reflex tests that was proposed by Ewing and Clarke for diagnosing CAN, as follows: the heart rate variation during deep breathing, the Valsalva maneuver and orthostatism and the tests of blood pressure variation during orthostatism (orthostatic hypotension) (Ziegler, 1994; Agelink et al., 2001; Spallone et al., 2011) .
In 2009, The Toronto Diabetic Neuropathy Expert Group provided updates on diagnostic criteria for CAN. The experts suggested to perform standardized tests to assess cardiac parasympathetic function (HR response to deep breathing, Valsalva and postural change) and cardiac sympathetic function (BP response to Valsalva and postural change) (Tesfaye et al., 2010) . The experts concluded that diagnostic criteria and staging of CAN are still a matter of debate but concluded that the presence of two abnormal tests is required for a confirmed diagnosis of CAN and the addition of orthostatic hypotension conferred severity to CAN diagnosis (Tesfaye et al., 2010) .
When calculating the reproducibility of methods, it is important to differentiate the intervention effects from measurement errors. Measurement errors can be divided into the following two main components: random and systematic errors. Random error is always present in a measurement and is not related to the clinical intervention because it is caused by inherently unpredictable fluctuations in the readings by the measuring equipment. In contrast, systematic errors are predictable biases in the measurement that are not related to the clinical intervention and that can be attributed to the experimental protocol. Therefore, they can be observed in all of the subjects, and they interfere directly with the accuracy of the measurement. In this situation, the effect of a clinical intervention must be greater than the systematic error for it to be detected and considered a real effect, regardless of the sample size. In contrast, random error directly affects the sample size required to achieve a sufficient power to detect the effects of a clinical intervention (Tibiriçá et al., 2011) . In the literature, there is no agreement on the period of fasting required before the tests are performed. According to Dyck and Thomas (1999) and Halsbeck et al. (2006) , a minimum of 8 h of fasting should occur before the autonomic tests because the post-prandial release of insulin that is stimulated by a meal could stimulate an increased release of norepinephrine and could possibly influence the heart rate and blood pressure. Spallone et al. (2011) suggests performing the tests when fasting or at least 2 h after a light meal, which was carried out in the present study. In the Hoorn Study (Gerritsen et al., 2000) , the participants were asked to refrain from smoking and drinking coffee for 2 h prior to the assessment of cardiovascular autonomic function, and the tests took place at least 1 h after a light meal.
The recommendations of the San Antonio Consensus Panel are as follows: each center needs to establish reference values based on the population studied and stratified by age because a pronounced age dependency of heart variability parameters has been recognized; a battery of quantitative tests must be used; independent tests of both parasympathetic and sympathetic functions must be performed; and more than one test should be abnormal to establish the presence of CAN (American Diabetes Association and American Academy of Neurology, 1988; Dyck and Thomas, 1999; Vinik et al., 2003) .
The main strength of the present study is that this is the first study conducted with the purpose of analyzing the reproducibility of the HRV parameters for assessing the autonomic nervous system in the Brazilian population. According to our study, we determined the minimum expected differences in the HRV variables based on the reproducibility of the data, which enables the calculation sample size for longitudinal clinical and testing drug studies.
Some limitations of our study include the lack of using a synchronized ventilation cycle by an external trigger because both HF and LF domains are influenced by fluctuations in the vagal modulation during respiration, the gender asymmetry and the small sample evaluated (Lobnig et al., 2003) .
Conclusion
This study showed that short-term spectral analysis of HRV (VLF, HF and LF) despite being a practical tool for screening CAN, demonstrated poor reproducibility. The evaluation of cardiovascular autonomic function, as determined by the tests proposed by Ewing (Valsalva ratio, deep breathing ratio and maximum:minimum ratio during orthostatism) in addition to some time-domain indices of HRV (CV, RRNN and SDNN), appears to provide good levels of reproducibility, which are similar to those obtained in previous studies.
According to our study, some tests that assess the HRV showed an adequate reproducibility. In view of our results, we propose the use of a statistical methodology to calculate the sample size in longitudinal clinical studies and studies testing drugs that takes into consideration the reproducibility of the autonomic tests.
